(Q40577770)

21 September 2017

1 reference

title

Possible mechanisms for the powerful actions of neuropeptides (English)

1 reference

21 September 2017

1

Fuxe K

1 reference

21 September 2017

Li XM

2

1 reference

21 September 2017

Bjelke B

3

1 reference

21 September 2017

Hedlund PB

4

1 reference

21 September 2017

Biagini G

5

1 reference

21 September 2017

Agnati LF

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 October 1994

1 reference

Annals of the New York Academy of Sciences

21 September 2017

published in

1 reference

21 September 2017

volume

739

1 reference

21 September 2017

page(s)

42-59

1 reference

Intramembrane receptor-receptor interactions: integration of signal transduction pathways in the nervous system

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Galanin and galanin antagonists: molecular and biochemical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Coinjections of NPY(1-36) or [Leu31,Pro34]NPY with adrenaline in the nucleus tractus solitarius of the rat counteract the vasodepressor responses to adrenaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and alpha 2-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

The C-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Receptors for neuropeptide Y: multiple subtypes and multiple second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Subpicomolar amounts of NPY(13-36) injected into the nucleus tractus solitarius of the rat counteract the cardiovascular responses to L-glutamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Region-specific inhibition of potassium-evoked [3H]noradrenaline release from rat brain synaptosomes by neuropeptide Y-(13-36). Involvement of NPY receptors of the Y2 type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Evidence for specific N-terminal galanin fragment binding sites in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Intracisternally injected galanin-(1-15) modulates the cardiovascular responses of galanin-(1-29) and the 5-HT1A receptor agonist 8-OH-DPAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

A novel 77-residue peptide from porcine brain contains a leucine-zipper motif and is recognized by an antiserum to delta-sleep-inducing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

L-cysteine, a bicarbonate-sensitive endogenous excitotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Beta-N-methylamino-L-alanine neurotoxicity: requirement for bicarbonate as a cofactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1994.TB19806.X

10.1111/J.1749-6632.1994.TB19806.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference